Differences

This shows you the differences between two versions of the page.

--- gerald_evans [2022/05/04 09:26]
liam [Kingston Health Sciences Centre]
+++ gerald_evans [2022/05/04 16:29] (current)
liam
@@ Line 10: / Line 10: @@
 Evans is the Chair of the Division of Infectious Diseases and a Professor in the Departments of Medicine, Biomedical & Molecular Sciences and Pathology & Molecular Medicine at [[Queen’s University]]. He was initially appointed to a faculty position at Queen’s in 1990.((//Evans | Department of Medicine | School of Medicine.// (2021, December 24). Wayback Machine; Queen’s University. https://archive.ph/45iGh))
 ==== Association of Medical Microbiology and Infectious Disease Canada ====
@@ Line 18: / Line 19: @@
 ==== Kingston Health Sciences Centre ====
-Evans is an attending physician in Infectious Diseases at [[Kingston Health Sciences Centre]], [[Hotel Dieu Hospital]], and [[Providence Care Hospital]]. Dr. Evans has been Medical Director of Infection Prevention & Control at the facilities since 2011.
+Evans is an attending physician in Infectious Diseases at [[Kingston Health Sciences Centre]], [[Hotel Dieu Hospital]], and [[Providence Care Hospital]].((//Gerald Evans.// KHSC Kingston Health Sciences Centre. Retrieved May 4, 2022, from https://archive.ph/qElPx)) Dr. Evans has been Medical Director of Infection Prevention & Control at the facilities since 2011.
+The facilities are funded through the [[University Hospitals Kingston Foundation]] by [[AmerisourceBergen]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Baxter]], [[pharmaceutical_companies:Bayer]], [[Bell]], [[BMO Financial Group]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Canadian Cancer Society]], [[CIBC]], [[Corus Entertainment]], [[Costco]], [[pharmaceutical_companies:Covidien]], [[General Electric]], [[IBM]], [[Imperial Oil]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[KPMG]], [[pharmaceutical_companies:LEO Pharma]], [[Loblaws]], [[Manulife Financial]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novopharm]], [[pharmaceutical_companies:Ortho Biotech]], [[pharmaceutical_companies:Paladin Laboratories]], [[PepsiCo]], [[pharmaceutical_companies:Pfizer]], [[Queen's University]], [[RBC (Royal Bank of Canada)]], [[RBC Foundation]], [[Rogers Media]], [[Ronald McDonald House Charities]], [[pharmaceutical_companies:Sanofi]], [[Scotiabank]], [[Shoppers Drug Mart]], [[medical_technology_companies:St. Jude Medical]], [[Sun Life Financial]], [[TC Energy]], [[TD Bank Group]], and [[TELUS]].((//Recognizing Your Contribution.// Kingston University Hospital Foundation. Retrieved May 4, 2022, from https://web.archive.org/web/20220504073124/https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution))
-The facilities are funded through the [[University Hospitals Kingston Foundation]] by [[AmerisourceBergen]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Baxter]], [[pharmaceutical_companies:Bayer]], [[Bell]], [[BMO Financial Group]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Canadian Cancer Society]], [[CIBC]], [[Corus Entertainment]], [[Costco]], [[pharmaceutical_companies:Covidien]], [[General Electric]], [[IBM]], [[Imperial Oil]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[KPMG]], [[pharmaceutical_companies:LEO Pharma]], [[Loblaws]], [[Manulife Financial]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Novopharm]], [[pharmaceutical_companies:Ortho Biotech]], [[pharmaceutical_companies:Paladin Laboratories]], [[PepsiCo]], [[pharmaceutical_companies:Pfizer]], [[Queen's University]], [[RBC (Royal Bank of Canada)]], [[RBC Foundation]], [[Rogers Media]], [[Ronald McDonald House Charities]], [[pharmaceutical_companies:Sanofi]], [[Scotiabank]], [[Shoppers Drug Mart]], [[medical_technology_companies:St. Jude Medical]], [[Sun Life Financial]], [[TC Energy]], [[TD Bank Group]], and [[TELUS]].
 ==== Ontario Ministry of Health and Long-Term Care ====
@@ Line 27: / Line 29: @@
 ==== Institute for Clinical Evaluative Sciences ====
-Evans is an Affiliate Scientist at the [[Institute for Clinical Evaluative Sciences]].
+Evans is an Affiliate Scientist at the [[Institute for Clinical Evaluative Sciences]].((//Gerald Evans.// Institute for Clinical Evaluative Sciences. Retrieved May 4, 2022, from https://www.ices.on.ca/About-ICES/ICES-Scientists/E/Gerald-Evans/Bio))
 ==== Public Health Ontario ====
 Evans is an Infection Prevention and Control (IPAC) consultant physician with [[Public Health Ontario]].
+==== Ontario Health ====
+Evans is a member of the [[Cancer Care Ontario]] subcommittee under [[Ontario Health]].((//Gerald Evans.// Institute for Clinical Evaluative Sciences. Retrieved May 4, 2022, from https://www.ices.on.ca/About-ICES/ICES-Scientists/E/Gerald-Evans/Bio))
 ==== Ontario Drug Policy Research Network ====
 Evans is a co-investigator with the [[Ontario Drug Policy Research Network]] (ODPRN), hosted at [[St. Michael's Hospital]] in [[canada:ontario:Toronto]].((//Core Academic Unit Members.// Ontario Drug Policy Research Network. Retrieved May 3, 2022, from https://archive.ph/MRjGj))
+==== Reformulary ====
+Evans is a member of the Expert Committee for [[Reformulary]], an evidence-based list of drugs reviewed and recommended by the panel.((//Reformulary Expert Committee Members and Special Advisors.// DrugFinder. Retrieved May 4, 2022, from https://archive.ph/XLi9P))
+==== Critical Care Canada forum ====
+Evans has participated as a speaker at the [[Critical Care Canada Forum]], the official meeting of the [[Canadian Critical Care Society]].((//Dr. Gerald Evans.// Critical Care Canada Forum. Retrieved May 4, 2022, from https://archive.ph/bTAYs)) The Forum's 2021 webinars were sponsored by [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Paladin Laboratories]], and [[medical_technology_companies:Masimo]].((//Sponsored Webinars 2021.// Critical Care Canada Forum. Retrieved May 4, 2022, from https://criticalcarecanada.com/sponsored-webinars-2021/))
+==== Canadian Lyme Disease Research Network ====
+Evans is a co-applicant on a grant for the [[Canadian Lyme Disease Research Network]], the project formerly led by Dr. [[Kieran Moore]].((//Gerald Evans Bio.// Canadian Lyme Disease Research Network. Retrieved May 4, 2022, from https://archive.ph/MMqiw))
 ==== Ontario COVID-19 Science Advisory Table ====
 Evans is a member of the [[Ontario COVID-19 Science Advisory Table]], including as a member of the Behavioural Science Working Group.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/))
+===== Research =====
+==== COVID-19 ====
+Evans received research funding from the [[Southeastern Ontario Academic Medical Organization]] (SOAMO) for "synthesis and preclinical testing of novel small molecule therapies for [[COVID‐19]]."((Evans, G. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220215130832/https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Gerald-Evans_20210827.pdf))
 ===== Relationship with Pharmaceutical Companies =====
 Evans has received research funding from [[pharmaceutical_companies:Biocryst]].((Stiver, H. G., Evans, G. A., Aoki, F. Y., Allen, U. D., & Laverdière, M. (2015). //Guidance on The Use of Antiviral Drugs for Influenza in Acute Care Facilities in Canada, 2014-2015.// Canadian Journal of Infectious Diseases and Medical Microbiology, 26(1), e5–e8. https://doi.org/10.1155/2015/371840))